Two Decades of Research Have Shown – Renadyl™ Helps Improve Kidney Function by Reducing Uremic Toxins
Renadyl™ is a patented, proprietary kidney health supplement which modulates the gut microbiome to support healthy BUN and creatinine levels, by reducing nitrogenous waste in the bowel and restoring healthy gut flora.
Renadyl™ is a blend of S. thermophilus (KB 19), L. acidophilus (KB27) and B. longum (KB31) strains of probiotic bacteria.
It was a pleasure meeting you at this year’s ASN Kidney Week Meeting in New Orleans. I had a wonderful time taking photos and chatting about Enteric Dialysis® (a.k.a Intestinal Dialysis™) and Kibow Biotech. Unfortunately, my hard drive is on the fritz, and I cannot seem to remember all of the photographs people took with me. Post a picture of us to your Facebook or Twitter account with the hashtag #Kibot to commemorate the wonderful time we had together. If you were lucky enough to have a dance with me, I’d love to watch the video of us together! Thanks again for the wonderful time in New Orleans. Love you, mean it, call me!
~ Dr. Kibot, Kibow Biotech Inc.
Download the PDF to know more about:
- Renadyl™- 3rd Biennial Customer Survey Results
- Enteric Dialysis® (a.k.a Intestinal Dialysis™) – Concept to Reality
- Possible Improvements in GFR of CKD Patients with Renadyl
- Cumulative Trial Findings
Kidney Week ASN 2017 – Flyer
About Kibow Biotech
Kibow Biotech is a biotechnology company founded in 1997, based in suburban Philadelphia and specializing in the development and commercialization of scientifically-formulated and clinically-tested probiotic dietary supplements. Kibow specializes in probiotic supplements for maintaining kidney health and boosting the immunity of the geriatric population by restoring their intestinal microflora. Established to help fight these rapidly growing health risks, Kibow provides the highest quality non-drug dietary supplements at affordable prices.
